Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net loss	$ (5,421,000)	$ (17,312,000)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	376,000	229,000
Stock-based compensation	3,993,000	3,509,000
Amortization of operating right-of-use assets	177,000	199,000
Non-cash interest expense	188,000	1,093,000
Change in fair value of Warrant liabilities	(3,943,000)	2,652,000
Change in fair value of Term Loan	0	(1,199,000)
Gain on marketable securities	0	(1,660,000)
Unrealized foreign exchange loss (gain)	95,000	(994,000)
Other noncash items	267,000	0
Change in operating assets and liabilities:
Trade accounts receivable	360,000	(42,000)
Inventories	(16,000)	(19,000)
Prepaid expenses and other current assets	172,000	(559,000)
Trade accounts payable	229,000	(538,000)
Accrued expenses and other current liabilities	(2,285,000)	2,597,000
Deferred revenue	(13,107,000)	(350,000)
Operating lease liability	(173,000)	343,000
Other non-current assets, net	(191,000)	(68,000)
Net cash used in operating activities	(19,279,000)	(12,119,000)
Cash flows from investing activities:
Purchase of property and equipment	(438,000)	(305,000)
Purchase of convertible note (Note 4)	0	(1,000,000)
Sales of marketable equity securities (Note 4)	0	254,000
Expenditures for internal-use software	(60,000)	(67,000)
Purchase of software	0	(87,000)
Net cash used in investing activities	(498,000)	(1,205,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in at-the-market offerings, net of issuance costs of $140	146,108,000	0
Proceeds from the issuance of common stock upon exercise of stock options	23,000	8,000
Proceeds from the issuance of common stock upon exercise of warrants	6,000	0
Payment of tax withheld pursuant to stock-based compensation settlements	(517,000)	(734,000)
Net cash provided by (used in) financing activities	145,620,000	(726,000)
Effect of exchange rate changes on cash and cash equivalents	498,000	47,000
Net increase (decrease) in cash and cash equivalents	126,341,000	(14,003,000)
Cash and cash equivalents at beginning of period	177,980,000	41,307,000
Cash and cash equivalents at end of period	304,321,000	27,304,000
Supplemental disclosure of non-cash investing and financing activities:
Capitalized stock-based compensation	53,000	0
Inventory applied to capital projects	0	18,000
Operating lease right-of-use assets exchanged for new operating lease obligations	0	365,000
Purchases of property and equipment included in accounts payable	0	234,000
Bonus settled in vested share based compensation awards	$ 0	$ 2,006,000